Live feed08:00:00·100dPRReleasevia QuantisnowMindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative DiseaseByQuantisnow·Wall Street's wire, on your screen.HYFT· MindWalk Holdings Corp.Health Care
